* Alignment Healthcare Inc ALHC.OQ ALHC.O is expected
to show
a rise in quarterly revenue when it reports results on August 1
for the period ending June 30 2024
* The Orange California-based company is expected to report
a
37.9% increase in revenue to $637.649 million from $462.38
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data.The company's guidance on May 2
2024, for the period ended June 30, was for revenue between
$625.00 million and $635.00 million.
* LSEG's mean analyst estimate for Alignment Healthcare Inc
is
for a loss of 14 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.4%
in the last three months.
* Wall Street's median 12-month price target for Alignment
Healthcare Inc is $8.50, below its last closing price
of $8.56.
The company's guidance on May 2 2024 for the period ended June
30 was for Earnings before Interest, Taxes, Depreciation and
Amortization of between 625 million and 6 million (USD).
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jan. 1 0001 -0.23 -0.22 -0.25 Missed -12.2
Dec. 31 0001 -0.22 -0.22 -0.25 Missed -12.5
Sep. 30 2023 -0.18 -0.18 -0.18 Met 1.4
Jun. 30 2023 -0.21 -0.22 -0.15 Beat 31.4
Mar. -0.26 -0.25 -0.20 Beat 21.4
31 2023
Dec. 31 2022 -0.30 -0.30 -0.31 Missed -4.3
Sep. 30 2022 -0.24 -0.25 -0.22 Beat 10.5
Jun. 30 2022 -0.26 -0.26 -0.06 Beat 76.7
This summary was machine generated July 30 at 20:40 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)